GMDA: great investment with 200% upside! Breakthrough drug!

NASDAQ:GMDA   Gamida Cell Ltd
Omidubicel currently has an FDA Breakthrough Designation which is "process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint"

Basically, this means that Omidubicel has so much potential, that the FDA wants to accelerate the approval process.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.